Refining the Provider Payment System of India?s Government Funded Health Insurance Program: An Econometric Analysis.
Prinja S, Bahuguna P, Singh MP, Guinness L, Goyal A, Aggarwal V
Validating the rigour of adaptive methods of economic evaluation.
Chauhan AS, Sharma D, Mehndiratta A, Gupta N, Garg B, Kumar AP, Prinja S
Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment.
Sharma D. Sharma D, Prinja S, Aggarwal AK, Rajsekar K, Bahuguna P.
Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Front Public Health.
Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N, Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S
Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.
Jyani G, Yang Z, Sharma A, Goyal A, Stolk E, Purba FD, Grover S, Kaur M, Prinja S
Cost of screening, out-of-pocket expenditure & quality of life for diabetes & hypertension in India. Indian J Med Res.
Brar S, Kaur G, Muniyandi M, Karikalan N, Bano H, Bhansali A, Jain S, Kumari S, Prinja S
Impact of India's publicly financed health insurance scheme on public sector district hospitals: a health financing perspective.
Prinja S, Singh MP, Aggarwal V, Rajsekar K, Gedam P, Goyal A, Bahuguna P.
Effect of tobacco taxation on smoking prevalence and smoking-attributable deaths in India. Indian J Public Health.
Rana K, Goel S, Prinja S
The impact of alternate methodological and structural assumptions on results of cost-effectiveness analysis: empirical evidence using three Indian economic evaluations.
Sharma D, Prinja S, Aggarwal AK, Bahuguna P.
Generic ibrutinib a potential costeffective strategy for the first-line treatment of chronic lymphocytic leukaemia
Hegde NC, Kumar A, Kaundal S, Saha L, Malhotra P, Prinja S, Lad D, Patil AN